The concentration-response relationships for the hepatocarcinogenic activity of dichloroacetic acid 2 (DCA) and trichloroacetic acid (TCA), two contaminants of finished drinking water, were determined in female B6C3F1 mice. Dichloroacetic acid or trichloroacetic acid at 2.0, 6.67, or 20.0 mmol/liter was administered to the mice in the drinking water starting at 7 to 8 weeks of age and until sacrifice after 360 or 576 days of exposure. The relationships of the yield of foci of altered hepatocytes, hepatocellular adenomas, and hepatocellular carcinomas to the concentration of DCA and TCA in the water were best described by second-order and linear regressions, respectively. The liver-to-body weight ratio increased linearly for both DCA and TCA, as did the vacuolization of the liver induced by DCA. The foci of altered hepatocytes and tumors in the animals treated with DCA were predominantly eosinophilic and contained glutathione S-transferase-7r (GST-TT, over 80% of the lesions), while the tumors induced by TCA were predominantly basophilic and lacked GST-TT, including all 11 hepatocellular carcinomas. Therefore, the carcinogenic activity of DCA and TCA appeared to differ both with respect to their dose-response relationship and to the characteristics of precancerous lesions and tumors.
DCA and TCA also induced liver tumors in male and female B6C3F1 mice (DeAngelo et ai, 1991; Bull et ai, 1990 : Anna et ai, 1994 . The U.S. EPA has used, in part, the results of these carcinogenesis bioassays in mouse liver and the radiomimetic linear multistage (LMS) model to calculate 10" 6 risk levels of 1.5 and 0.56 //,mol/liter for DCA and TCA in drinking water, respectively.
The mechanism for the hepatocarcinogenic activity of these two chloroacetic acids appears not to result from genotoxic activity, as in vitro and in vivo tests for genotoxicity have not demonstrated significant activity (Waskel, 1978; Rapson et ai, 1980; Herbert et ai, 1980; Chang et ai, 1992) . Also, DCA has been shown to induce liver tumors that did not contain a unique mutation spectrum in either the H-or K-ras oncogene, but rather mutations in the 61st codon of the H-ras oncogene common to spontaneous tumors in B6C3F1 mice, albeit in a smaller percentage of the tumors (Anna et ai, 1994) . DCA and TCA do induce the proliferation of peroxisomes in the liver of mice (Elcome, 1985; Elcome et ai, 1985; Goldworthy and Popp, 1987; Odum et ai, 1988) , an activity shared with some other hepatocarcinogens. This paper reports the concentration-response relationship for the carcinogenic activity of DCA and TCA that was previously identified by us in female B6C3F1 mice (Herren-Freund etai, 1987) . The concentrationresponse relationship and the characteristics of the lesions induced by DCA and TCA support different pathogeneses for the two chloroacetic acids.
MATERIALS AND METHODS

Animals and chemicals.
VAF (viral antibody-free) female B6C3F1 mice at 5 to 6 weeks of age were purchased from Charles River Breeding Laboratories (Portage. MI). The animals were housed in an AAALACaccredited facility and in accordance with the U S Public Health Service "Guide for the Care and Use of Laboratory Animals." The Institutional Animal Care and Use Committee at Environmental Health Research and Testing approved the experiment. A maximum of five mice/cage were housed using solid-bottom polycarbonate cages with stainless steel wirebar lids. The bedding consisted of SaniChip (hardwood) bedding purchased from P. J. Murphy Forest Products (Montville. NJ). The animals were provided ad libitum with rodent pelletized NIH-07 Open Formula diet (Ziegler Brothers, Gardners. PA) and deionized and filtered (0.2 fim) drinking water. The light cycle consisted of 14 hr of light and 10 hr of dark.
Experimental design. When the mice were 7-8 weeks of age. they started to receive in their drinking water either DCA or TCA at 2.0. 6.67, or 20.0 mmol/liter and neutralized with sodium hydroxide to pH 6.5-7.5. The control group received 20.0 mmol/liter sodium chloride (control for sodium salt). The DCA was purchased from Eastman Kodak Co. (Rochester, NY) and the TCA and sodium chloride from Fisher Scientific Co. (Pittsburgh, PA). The concentrations of DCA and TCA were chosen so that the high concentration was comparable to those previously used by us to demonstrate carcinogenic activity in female B6C3F1 mice (Herren-Freund et at, 1987) . The chloroacetic acid solutions were administered continuously to the mice until they were sacrificed by carbon dioxide asphyxiation after either 360 or 576 days of exposure. An exception was the group of mice exposed to 20.0 mmol/liter DCA in a 72-day cycle consisting of 24 days of exposure followed by 48 days without exposure. The 11-foy cycle was repeated until the animals were sacrificed which resulted in the same total dose as that received by the animals continuously exposed to 6.67 mmol/liter, thus allowing comparison of the carcinogenic activity of the same total dose administered by continuous exposure to that of an intermittent exposure. The 24 days of exposure in the intermittent group was chosen to ensure that any enhancement of cell proliferation induced by DCA had ceased (see Results). The number of animals in each treatment group at the start of the study is presented in Table I . Drinking water consumption and body weights were monitored during the first 4 weeks of the experiment and monthly thereafter.
The animals were sacrificed after 360 or 576 days of exposure so that the sacrifice occurred at the end of either five or eight cycles of intermittent exposure to DCA. The terminal sacrifice for the experiment occurred at 576 days when it became apparent that liver tumors as indicated by a distended abdomen were present and that some of the animals receiving the high concentration of TCA were becoming moribund. Thus, it appeared that these animals could not survive another 72 days required to complete a cycle of intermittent exposure to DCA. During the necropsy, the liver was excised, weighed, and examined for lesions. The whole liver was cut into ~3-mm blocks and along with representative sections of the visible lesions fixed in 10% neutral phosphate-buffered formalin for approximately 18 hr, transferred to 70% alcohol, and within 48 hr embedded in paraffin. The blocks were sectioned at 5 /zm and stained with hematoxylin and eosin for histopathological evaluation for foci of altered hepatocytes. hepatocellular adenomas, and hepatocellular carcinomas. The slides were evaluated blind, being identified only by the study number and the random number assigned to the animal. Foci of altered hepatocytes in this study contained six or more cells and hepatocellular adenomas were distinguished from foci by the occurrence of compression at greater than 80% of the border of the lesion. The extent of vacuolation in the liver of DCA-treated mice was scored using a 0 to +3 scale, with 0 indicating the absence of vacuolation, +1 indicating vacuolated hepatocytes in the penportal zone, +2 indicating distribution of vacuolated hepatocytes in the midzone, and +3 indicating maximum vacuolation of the hepatocytes throughout the liver.
Cell proliferation and glutathione S-transferase-u.
Cell proliferation was determined in treatment groups containing 10 mice each and exposed to either DCA or TCA for 5, 12, or 33 days. Five days prior to sacrifice, mice were implanted with an osmatic minipump (Alzet Corp., Palo Alto, CA) containing 30 mg/ml bromodeoxyundine (BrDU) and designed to deliver 1 /il/hr. Tissue blocks were sectioned at 5 //m and immunohistochemically stained for BrDU incorporation by the procedure of Sugihara et al. (1986) using monoclonal rat anti-BrDU antibody (Accurate Chemical and Scientific Corp., Westbury, NY). At least 2000 hepatocytes/mouse were evaluated for BrDU-labeled and unlabeled nuclei and the BrDU-labeling index was calculated as the percentage of hepatocytes with labeled nuclei.
Glutathione 5-transferase-?r (GST-TT) was detected by the avidin-biotin peroxidase complex method employing rabbit NCL-GST-7T from human chronic lymphoblast leukemic spleen (Novocastra Laboratory, Ltd., Newcastle upon Tyne, UK), goat blocking serum. Vector kit PK-4001 and counterstaining with hematoxylin. Serial sections were stained with hematoxylin and eosin. The controls for nonspecific staining included (1) nonimmunized rabbit serum used instead of the rat anti-BrDU antibody or the rabbit NCL-GST-TT and (2) the performance of the staining procedures without the primary or the secondary antibody. None of these negative controls demonstrated significant staining.
RESULTS
Drinking Water Consumption and Body and Liver Weights
The drinking water consumption during the first 4 weeks of exposure to the chloroacetic acids is presented in Table 1 . During the first week of exposure, only the high concentration group of both DCA and TCA exhibited a decrease in drinking water consumption. Thereafter, no effect of exposure to either DCA or TCA including the monthly monitoring of consumption (data not given) was observed except for a sporadic decrease or increase in a single treatment group.
The body weights of the animals during the course of the study are presented in Fig. 1 . The body weights of the mice that received 20.0 mmol/liter DCA were reduced after 35 weeks of exposure, with neither of the two other DCA treatment groups demonstrating an effect. After 51 weeks of exposure to 20.0 mmol/liter TCA, there was a trend of reduced body weights with some of the times monitored being statistically significant. The two lower concentrations of TCA did not effect the body weight of the animals. Figure  2 presents the concentration relationships of the liver-tobody weight ratio obtained after 360 and 576 days of exposure. The increase in liver-to-body weight ratio was linearly related to the concentration of DCA or TCA in the drinking water; the linear regression coefficients (r) were equaled to 0.9917 and 0.9925 at 360 days and 0.9994 and 0.9861 at 576 days, respectively. DCA exerted a greater effect than TCA upon the ratio. The low number of tumors at 360 days and the fact that the liver-to-body weight ratio did not increase with the increase in tumor response between 360 and 576 days argues against the greater ratio in DCA-treated mice being due to an increased tumor burden.
Upon histopathologic evaluation, the liver from the animals treated with DCA contained vacuolated hepatocytes. The extent of vacuolation of the hepatocytes in the mice administered 0, 2.0, 6.67, or 20.0 mmol/liter DCA was scored as 0.0. 0.80 ± 0.08, 2.32 ± 0.11, or 2.95 ± 0.05, respectively, using the scale of 0 to +3. Hence, all three concentrations of DCA resulted in vacuolation of hepatocytes. Table 2 contains the incidence (number and percentage of animals with a lesion) and Table 3 the yield (lesions/ mouse) of foci of altered hepatocytes, hepatocellular adenomas, and hepatocellular carcinomas in mice administered DCA or TCA. After 360 days of exposure, in mice adminis- " N indicates the number of animals at the start of the study. * Results are means ± SE expressed as ml/mouse/day. * Significantly different from Group 7 (NaCl vehicle) by an ANOVA followed by a pair test with Bonferroni's correction, p value <0.05 tered DCA, the incidence and yield of foci of altered hepatocytes and hepatocellular adenomas were increased only by 20.0 mmol/liter, while after 576 days of exposure 6.67 mmol/liter also increased the yield of foci and adenomas. The higher concentration of DCA at 576 days also increased the incidence and yield of hepatocellular carcinomas. In the group of mice that received intermittent exposure to DCA, i.e., 72-day cycle consisting of 24 weeks of 20.0 mmol/liter DCA followed by 48 days without exposure, the only effect observed was an increase in foci of altered hepatocytes after 576 days. There was no significant difference between the treatment group that intermittently received 20.0 mmol/liter DCA and the group that received the same total exposure of DCA but administered continuously as 6.67 mmol/liter. With respect to TCA, after 360 days the high concentration group ( were obtained for the foci and tumor response in mice treated with TCA.
Foci and Tumor Response
The yield of total lesions (foci + adenomas + carcinomas) versus the concentration of DCA or TCA in drinking water is presented graphically in Fig. 3 . Regression analysis indicated that the response of total lesions was linearly related to the concentration of TCA with a correlation coefficient of 0.9979. The correlation coefficient for the regression analysis of the total lesions produced by DCA was only 0.9627 for first order and 0.9998 for second order. Therefore, Fig.  3 presents the second-order regression line for the total lesion response to DCA. The dose-response relationship for the yield of tumors (adenomas + carcinomas) was also linear for TCA and second order for DCA (data given in Table 3 ). Mice were administered DCA, TCA, or NAC1 in their drinking water starting at 7-8 weeks of age. The mice continued to receive the test agents until sacrificed after either 360 or 576 days of exposure.
* The results indicate the number of animals with lesions (foci of altered hepatocytes, hepatocellular adenomas or hepatocellular carcinomas) with the number in parentheses being the percentage of animals.
''The mice received 20.0 mmol/liter DCA in their drinking water starting at 7-8 weeks of age and for a total of 24 days followed by 48 days without exposure. The 72-day cycle was repeated until the mice were euthanized. * p value < 0.05 by Fisher's exact test. The foci of altered hepatocytes and the tumors obtained from this study were basophilic, eosinophilic, or mixed containing both characteristics (Table 4) sinophilic with the rest being basophilic, in both the treatment group intermittently exposed to DCA and the group administered 2.0 mmol/liter DCA. The percentage of the lesions characterized as eosinophilic in the group intermittently exposed to DCA was significantly less than in the groups that were administered either 6.67 or 20.0 mmol/liter DCA {p value <0.05). The eosinophilic foci and tumors consistently stained immunohistochemically for the presence of GST-TT, while basophilic lesions did not stain for GST-7T, except for a few scattered cells or small areas comprising less than 10% of the lesion.
The foci of altered hepatocytes in the TCA treatment groups were approximately equally distributed between basophilic and eosinophilic in tincture. However, the tumors were predominantly basophilic lacking GST-TT (21 of 28, 75%) including all 11 hepatocellular carcinomas. Since a higher percentage of tumors compared to foci were basophilic, it would suggest that in TCA-treated animals basophilic foci compared to eosinophilic foci have a greater tendency to progress tumors. The limited numbers of lesions, i.e., 14, in the sodium chloride (vehicle control) group were characterized as 64.3, 28.6, and 7.1% basophilic, eosinophilic, and mixed, respectively.
Cell Proliferation
The BrDU-labeling index in DCA-and TCA-treated mice is presented in Figs. 4A and 4B , respectively. Five days of exposure to DCA resulted in a concentration-dependent increase in the BrDU-labeling index. However, after 12 and 33 days of exposure to DCA, the BrDU-labeling index was no longer altered, although at 12 days there was a nonsignificant trend for an increase in the BrDU-labeling index. TCA also increased the BrDU-labeling index only after 5 days of exposure with all three concentrations producing approximately the same increase. 
DISCUSSION
Dichloroacetic acid and trichloroacetic acid are found as byproducts of chlorination in finished drinking water at concentrations of 34 to 160 /zg/liter Krasner et al., 1989) . The chloroacetic acids are also metabolites of trichloroethylene and tetrachloroethylene (Elcome, 1985; Goldworthy and Popp, 1987; Odum et ai, 1988; Dekant et ai, 1984) , two widely used industrial solvents that are common contaminants of surface water, groundwater, and drinking water, as well as soil and lysates of landfill hazardous waste disposal sites (Coleman et ai, 1976; Conglioet ai, 1980; Westrick era/., 1984) . Exposure of B6C3F1 mice to DCA or TCA in the drinking water has been shown to produce liver tumors (Herren-Freund et al., 1987; DeAngelo et al., 1991) . The U.S. EPA using a LMS model has applied these previous results to calculate 10~6 risk levels of 1.5 and 0.56 ^mol/liter for DCA and TCA in drinking water, respectively. Determination of the dose-response relationship for the carcinogenic activity of DCA and TCA would improve the estimation of their carcinogenic hazard to humans.
The tumorigenic activity of TCA exhibited a linear relationship to its concentration in drinking water, in contrast to the second-order relationship exhibited by DCA. In male B6C3F1 mice, DeAngelo etal. (1991) also appeared to have observed an exponential dose-response relationship for DCA, in which 26.9 but not 3.84 mmol/liter increased the yield of liver tumors. Their reported tumor response in male mice of 4.0 tumors/animals after 420 days of exposure to 26.9 mmol/liter DCA (DeAngelo et ai, 1991) was similar to the 5.95 tumors/animals observed by us in female mice exposed to 20.0 mmol/liter. Thus, female and male mice would appear to be of similar sensitivity to DCA. The exponential increase in the tumorigenic potency of DCA did not correlate with the linear relationships for DCA (1) induced increase in the liver-to-body weight ratio; (2) enhancement of the BrDU-labeling index after 5 days of exposure; and (3) induced vacuolation of the liver that stained with PAS, indicating an accumulation of glycogen. This would suggest that the dose of DCA to the liver does not increase exponentially with its concentration in the drinking water.
DCA administered intermittently as a 72-day cycle consisting of 24 days of exposure to 20.0 mmol/liter followed by 48 days without exposure resulted in a very low yield of foci and tumors. This group was included in the study in order to determine whether the carcinogenic activity of intermittent exposure to DCA is equal to the activity of the same total dose given continuously. However, both the intermittent exposure to 20.0 mmol/liter DCA and the continuous exposure to 6.67 mmol/liter DCA induced only a very low yield of foci and tumors. The total exposure to DCA in these two treatment groups was one-third that of the group continuously exposed to 20.0 mmol/liter, so that it was expected that the yield of foci and tumors would be one-third that of the 20.0 mmol/liter treatment group. Instead, the yield of these lesions was less than 1 /20th of the group exposed continuously to 20.0 mmol/liter. One possible explanation for the low tumorigenic potency of intermittent exposure to 20.0 mmol/liter DCA is that the lesions induced by DCA were not stable but regress during the 48 days in which the animals were not exposed to DCA. We have unpublished evidence that foci of altered hepatocytes and hepatocellular adenomas initiated by methylnitrosourea and promoted by DCA regress upon termination of exposure to DCA. Thus, at the beginning of the next exposure to DCA, the pathogenesis of the lesions would commence with less advanced lesions than those present when the previous exposure ceased.
The characteristics of the foci and tumors induced by DCA and TCA further suggest different mechanisms of action. The foci and tumors induced by DCA were greater than 80% eosinophilic and contained GST-TT; however, the tumors induced by TCA were predominantly basophilic lacking GST-TT. The characteristics of foci and tumors of mouse liver have been previously reported to be carcinogen specific (Ward et ai, 1983; Dragani et ai, 1985; Weghorst and Klaunig, 1989; Hatayama et ai, 1993) . Liver tumors in mice not administered a carcinogen or those induced by diethylnitrosamine have been reported to be predominantly basophilic and lacking GST-7T (Ward et ai, 1983; Dragani et ai, 1985; Weghorst and Klaunig, 1989; Hatayama et ai, 1993) . When diethylnitrosamine-initiated mice were promoted with phenobarbital or l,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP), the resulting foci and tumors were then predominantly eosinophilic (Ward et ai, 1983; Dragani et ai, 1985; Weghorst and Klaunig, 1989; Hatayama et ai, 1993; Diwan et ai, 1992) and in female but not male mice promoted with phenobarbital contained GST-TT (Hatayama et ai, 1993) . Chronic administration to mice of phenobarbital (Evans et ai, 1992) or nitrofen (Hoover et ai, 1980 ) also resulted in eosinophilic tumors. In contrast, promotion of diethylnitrosamine-initiated mice with di(2-ethylhexyl)phthalate, a peroxisome proliferator, resulted in foci of altered hepatocytes and tumors that were basophilic (Ward et ai, 1983; Standeven and Goldworthy, 1993) . Marsman and Popp (1994) have shown in rats that peroxisome proliferators also induce basophilic foci and tumors. Both DCA and TCA are peroxisome proliferators in mice and rats (Elcome, 1985; Elcome et ai, 1985; Goldworthy and Popp, 1987; Odum et ai, 1988) . In summary, the basophilic staining of the tumors induced by TCA is consistent with other peroxisome proliferators, while the eosinophilic staining of those induced by DCA is not consistent. Furthermore, the differences in the characteristics of the tumors induced by DCA and TCA as well as the different shape of their concentration-response relationships would suggest different pathogeneses and mechanisms.
